or Try an Advanced Search...

    Technical Analysis for VINC - Vincera Pharma, Inc.

    Grade Last Price % Change Price Change
    F 0.37 4.58% 0.02
    VINC closed up 4.58 percent on Friday, November 1, 2024, on 19 percent of normal volume.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VINC trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    New 52 Week Closing Low Bearish 4.58%
    NR7 Range Contraction 4.58%
    Narrow Range Bar Range Contraction 4.58%
    New 52 Week Low Weakness 4.58%
    Wide Bands Range Expansion 4.58%
    Down 3 Days in a Row Weakness 4.58%
    Down 4 Days in a Row Weakness 4.58%
    Down 5 Days in a Row Weakness 4.58%
    Oversold Stochastic Weakness 4.58%
    Older End-of-Day Signals for VINC ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 23 hours ago
    Down 3% about 23 hours ago
    Up 3% about 23 hours ago
    Down 2 % about 23 hours ago
    Down 1% about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VINC Chart by TradingView
    Basic chart:

    Profile

    Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology

    Is VINC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 10 What Makes Vincerx Pharma (VINC) a New Buy Stock
    Oct 8 Vincerx stock tumbles 20% on corporate updates
    Oct 7 Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
    Aug 21 Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky
    Aug 9 Vincerx Pharma GAAP EPS of -$0.05
    Aug 8 Vincerx Pharma Reports Second Quarter 2024 Financial Results
    Jun 27 Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade
    May 15 Vincerx Pharma GAAP EPS of -$0.58
    May 14 Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
    See more VINC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.3722
    52 Week Low 0.33
    Average Volume 570,445
    200-Day Moving Average 1.56
    50-Day Moving Average 0.60
    20-Day Moving Average 0.40
    10-Day Moving Average 0.37
    Average True Range 0.04
    RSI (14) 31.97
    ADX 38.29
    +DI 13.47
    -DI 31.94
    Chandelier Exit (Long, 3 ATRs) 0.64
    Chandelier Exit (Short, 3 ATRs) 0.45
    Upper Bollinger Bands 0.54
    Lower Bollinger Band 0.25
    Percent B (%b) 0.39
    BandWidth 71.59
    MACD Line -0.07
    MACD Signal Line -0.07
    MACD Histogram 0.0063
    Fundamentals Value
    Market Cap 7.8 Million
    Num Shares 21.4 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 0.00
    Price-to-Book 1.83
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.41
    Resistance 3 (R3) 0.41 0.39 0.40
    Resistance 2 (R2) 0.39 0.37 0.39 0.40
    Resistance 1 (R1) 0.38 0.37 0.38 0.38 0.40
    Pivot Point 0.35 0.35 0.36 0.36 0.35
    Support 1 (S1) 0.34 0.34 0.35 0.35 0.33
    Support 2 (S2) 0.32 0.34 0.33 0.33
    Support 3 (S3) 0.31 0.32 0.33
    Support 4 (S4) 0.32